| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.009 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |